These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16229161)

  • 1. Purification and identification of multiple forms of dynorphin in human placenta.
    Lemaire S; Valette A; Chouinard L; Dupuis N; Day R; Porthé G; Cros J
    Neuropeptides; 1983 Jan; 3(3):181-91. PubMed ID: 16229161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of immunoreactive dynorphin in human phaeochromocytomas.
    Howlett TA; Besser GM; Rees LH
    J Endocrinol; 1988 Apr; 117(1):123-32. PubMed ID: 2895797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynorphin peptides in human substantia nigra.
    Christensson-Nylander I; Terenius L
    Neuropeptides; 1985 Sep; 6(5):391-6. PubMed ID: 2865698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynorphin and enkephalins in adrenal paraneurones. Opiates in the adrenal medulla.
    Lemaire S; Day R; Dumont M; Chouinard L; Calvert R
    Can J Physiol Pharmacol; 1984 Apr; 62(4):484-92. PubMed ID: 6203634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreactive dynorphine in maternal blood, umbilical vein and amniotic fluid.
    Valette A; Desprat R; Cros J; Pontonnier G; Belisle S; Lemaire S
    Neuropeptides; 1986; 7(2):145-51. PubMed ID: 2871518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynorphin A-(1-17) and dynorphin B are released from in vitro superfused rat hypothalami. Effects of depolarizing agents and ovariectomy.
    Spampinato S; Canossa M; Bachetti T; Campana G; Murari G; Ferri S
    Brain Res; 1992 May; 580(1-2):225-32. PubMed ID: 1354557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of heart dynorphin-A in the development of spontaneously hypertensive rats.
    Dumont M; Sabourin L; Lemaire S
    Neuropeptides; 1990 Jan; 15(1):43-8. PubMed ID: 1970135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of immunoreactive dynorphin B-like material in human, rat, rabbit and guinea-pig heart.
    Spampinato S; Canossa M; Ventura C; Bachetti T; Venturini R; Bastagli L; Bernardi P; Ferri S
    Life Sci; 1991; 48(6):551-9. PubMed ID: 1671525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of big dynorphins from rat brain and spinal cord.
    Xie GX; Goldstein A
    J Neurosci; 1987 Jul; 7(7):2049-55. PubMed ID: 2886564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and localization of immunoreactive dynorphin, alpha-neo-endorphin, Met-enkephalin and substance P in human spinal cord.
    Przewłocki R; Gramsch C; Pasi A; Herz A
    Brain Res; 1983 Nov; 280(1):95-103. PubMed ID: 6197139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus.
    Chavkin C; Bakhit C; Weber E; Bloom FE
    Proc Natl Acad Sci U S A; 1983 Dec; 80(24):7669-73. PubMed ID: 6143317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive dynorphin in rat tissues and plasma.
    Spampinato S; Goldstein A
    Neuropeptides; 1983 Jan; 3(3):193-212. PubMed ID: 16229162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoreactive dynorphin in human brain and pituitary.
    Gramsch C; Höllt V; Pasi A; Mehraein P; Herz A
    Brain Res; 1982 Feb; 233(1):65-74. PubMed ID: 6120742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corelease of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro.
    Knepel W; Schwaninger M; Döhler KD
    Endocrinology; 1985 Aug; 117(2):481-7. PubMed ID: 2862008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in regional concentrations of endogenous opioids following traumatic brain injury in the cat.
    McIntosh TK; Head VA; Faden AI
    Brain Res; 1987 Nov; 425(2):225-33. PubMed ID: 2892572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Levels of dynorphin-(1-13) immunoreactivity in rat neurointermediate pituitaries are concomitantly altered with those of leucine enkephalin and vasopressin in response to various endocrine manipulations.
    Höllt V; Haarmann I; Seizinger BR; Herz A
    Neuroendocrinology; 1981 Dec; 33(6):333-9. PubMed ID: 6275285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct distribution of immunoreactive dynorphin and leucine enkephalin in various populations of isolated adrenal cromaffin cells.
    Dumont M; Day R; Lemaire S
    Life Sci; 1983 Jan; 32(3):287-94. PubMed ID: 6130460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
    Dumont M; Lemaire S
    J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a differential postnatal development of proenkephalin B (= prodynorphin)-derived opioid peptides in the rat hypothalamus.
    Seizinger BR; Grimm C; Herz A
    Endocrinology; 1984 Sep; 115(3):926-35. PubMed ID: 6547667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoreactive dynorphin A-like material in extracted human hypothalamic-hypophysial plasma.
    Spampinato S; Paradisi R; Canossa M; Campana G; Frank G; Flamigni C; Ferri S
    Life Sci; 1993; 52(2):223-30. PubMed ID: 8102766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.